Your browser doesn't support javascript.
loading
Clarithromycin-Associated Acute Liver Failure Leading to Fatal, Massive Upper Gastrointestinal Hemorrhage from Profound Coagulopathy: Case Report and Systematic Literature Review.
Edhi, Ahmed I; Hakim, Seifeldin; Shams, Christienne; Bedi, Damanpreet; Amin, Mitual; Cappell, Mitchell S.
Afiliação
  • Edhi AI; Division of Gastroenterology & Hepatology, Department of Medicine, William Beaumont Hospital, 3535 W Thirteen Mile Rd, Royal Oak, MI 48073, USA.
  • Hakim S; Division of Gastroenterology & Hepatology, Department of Medicine, William Beaumont Hospital, 3535 W Thirteen Mile Rd, Royal Oak, MI 48073, USA.
  • Shams C; Department of Medicine, William Beaumont Hospital, Oakland University William Beaumont School of Medicine, 3535 W Thirteen Mile Rd, Royal Oak, MI 48073, USA.
  • Bedi D; Transplant Surgery, Department of Surgery, William Beaumont School of Medicine, 3601 W Thirteen Mile Rd, Royal Oak, MI 48073, USA.
  • Amin M; Department of Pathology, William Beaumont Hospital, Oakland University William Beaumont School of Medicine, 3601 W Thirteen Mile Rd, Royal Oak, MI 48073, USA.
  • Cappell MS; Division of Gastroenterology & Hepatology, Department of Medicine, William Beaumont Hospital, 3535 W Thirteen Mile Rd, Royal Oak, MI 48073, USA.
Case Reports Hepatol ; 2020: 2135239, 2020.
Article em En | MEDLINE | ID: mdl-32148980
While erythromycin has caused numerous cases of acute liver failure (ALF), clarithromycin, a similar macrolide antibiotic, has caused only six reported cases of ALF. A new case of clarithromycin-associated ALF is reported with hepatic histopathology and exclusion of other etiologies by extensive workup, and the syndrome of clarithromycin-associated ALF is better characterized by systematic review. A 60-year-old nonalcoholic man, with normal baseline liver function tests, was admitted with diffuse abdominal pain and AST = 499 U/L and ALT = 539 U/L, six days after completing a 7-day course of clarithromycin 500 mg twice daily for suspected upper respiratory infection. AST and ALT each rose to about 1,000 U/L on day-2 of admission, and rose to ≥6,000 U/L on day-3, with development of severe hepatic encephalopathy and severe coagulopathy. Planned liver biopsy was cancelled due to coagulopathies. Extensive evaluation for infectious, immunologic, and metabolic causes of liver disease was negative. Abdominal computerized tomography and abdominal ultrasound with Doppler were unremarkable. The patient developed massive, acute upper gastrointestinal bleeding associated with coagulopathies. Esophagogastroduodenoscopy was planned after massive blood product transfusions, but the patient rapidly expired from hemorrhagic shock. Autopsy revealed a golden-brown heavy liver with massive hepatic necrosis and sinusoidal congestion. Rise of AST/ALT to about 1,000 U/L each was temporally incompatible with shock liver because this rise preceded the hemorrhagic shock, but the subsequent AST/ALT rise to ≥6,000 U/L each may have had a component of shock liver. The six previously reported cases were limited by failure to exclude hepatitis E (4), lack of liver biopsy (2), and uninterpretable liver biopsy (1) and by confounding potential etiologies including disulfiram, israpidine, or recent acetaminophen use (3), clarithromycin overdose (1), active alcohol use (1), and severe heart failure (1). Review of 6 previously reported and current case of clarithromycin-associated ALF revealed that patients had AST and ALT values in the thousands. Five patients died and 2 survived.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2020 Tipo de documento: Article